STOCK TITAN

MEDWELLAI INC (MWAI) Financials

MWAI
FY2025 annual
Revenue $595K YoY not available
Net Income -$3.6M +68.7% YoY
EPS (Diluted) -$0.49 YoY not available
Free Cash Flow -$851K +79.4% YoY
Source SEC Filings (10-K/10-Q) Latest period Q3 FY2026, ended Mar 31, 2026 Reported Currency USD FYE June

Newest figures come from the 10-Q for Q3 FY2026, filed May 5, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the MWAI SEC filings page.

MEDWELLAI INC (MWAI) reported $595K in revenue for fiscal year 2025. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI MWAI FY2025

FY2025’s small sales base supported continued losses, cash consumption despite minimal reinvestment, and a liability-heavy balance sheet.

Revenue fell from $3.9M in FY2023 to just $595K in FY2025, so the smaller absolute loss reflects a much smaller operation rather than an established recovery. The latest net margin was -606.5%, showing that fixed and operating costs remained disproportionate to the remaining sales base.

Cash conversion was better than the reported bottom line but still negative: operating cash flow was -$849K against a net loss of $3.6M. Free cash flow of -$851K nearly matched operating cash flow while capital expenditures were only $2K, indicating that the cash shortfall was not primarily caused by reinvestment.

The balance-sheet posture became more constrained across the available periods: the current ratio fell from 0.3x in FY2022 to 0.1x in FY2025, leaving little current-asset coverage for near-term obligations. FY2025 liabilities of $7.4M were many times total assets of $806K, making the company’s financing structure dominated by obligations rather than owned assets.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Financial health score not available

MEDWELLAI INC does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.

Piotroski F-Score Partial
2/7

MEDWELLAI INC passes 2 of 7 computable financial strength tests (2 of the nine could not be computed from available data). 1 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), both operating efficiency signals pass.

Earnings Quality No Cash Backing
N/A

MEDWELLAI INC reported a net loss of $3.6M while operations used $849K of cash. With neither figure positive, the ratio between the two carries no quality signal.

Interest Coverage At Risk
N/A

MEDWELLAI INC reported an operating loss of $2.8M against $52K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$619K
YoY+119.9%
QoQ+12.8%

MEDWELLAI INC generated $619K in revenue in Q3 2026. This represents an increase of 119.9% from the same quarter a year earlier. Against the prior quarter it is up 12.8%.

EBITDA
-$213K
YoY+73.2%
QoQ+17.7%

MEDWELLAI INC's EBITDA was -$213K in Q3 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 73.2% from the same quarter a year earlier. Against the prior quarter it is up 17.7%.

Net Income
-$240K
YoY+59.2%
QoQ+16.4%

MEDWELLAI INC reported -$240K in net income in Q3 2026. This represents an increase of 59.2% from the same quarter a year earlier. Against the prior quarter it is up 16.4%.

EPS (Diluted)
-$0.04
YoY+60.0%
QoQ+20.0%

MEDWELLAI INC earned -$0.04 per diluted share (EPS) in Q3 2026. This represents an increase of 60.0% from the same quarter a year earlier. Against the prior quarter it is up 20.0%.

Cash & Balance Sheet

Free Cash Flow
-$7K
YoY+97.3%

MEDWELLAI INC recorded an outflow of $7K in free cash flow in Q3 2026, representing a cash shortfall after capex. This represents an increase of 97.3% from the same quarter a year earlier.

Cash & Debt
$130K
YoY-73.0%
QoQ-5.4%
5Y CAGR+5.4%
10Y CAGR+26.5%

MEDWELLAI INC held $130K in cash as of Q3 2026; long-term debt is not reported for that period.

Shares Outstanding
7M
YoY+6.5%
QoQ+4.8%

MEDWELLAI INC had 7M shares outstanding in Q3 2026. This represents an increase of 6.5% from the same quarter a year earlier. Against the prior quarter it is up 4.8%.

Dividends Per Share

Not reported for Q3 2026.

Margins & Returns

Operating Margin
-36.8%
QoQ+13.1pp

MEDWELLAI INC's operating margin was -36.8% in Q3 2026, reflecting core business profitability. Against the prior quarter it is up 13.1 percentage points. No change is given against Q3 2025: its reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.

Net Margin
-38.8%
QoQ+13.6pp

MEDWELLAI INC's net profit margin was -38.8% in Q3 2026, showing the share of revenue converted to profit. Against the prior quarter it is up 13.6 percentage points. No change is given against Q3 2025: its reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.

Gross Margin

Not reported for Q3 2026.

Return on Equity

Not reported for Q3 2026.

Capital Allocation

Capital Expenditures
$0

MEDWELLAI INC reported no capital expenditure in Q3 2026.

R&D Spending

Not reported for Q3 2026.

Share Buybacks

Not reported for Q3 2026.

MWAI Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

MWAI quarterly income statement
MetricQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-K
Revenue$619K+119.9%$548K+283.8%$96K+8270.6%$169K$281K-85.8%$143K-91.7%$1K-99.9%N/A
Cost of RevenueN/AN/AN/AN/A$0-100.0%$0-100.0%$0-100.0%N/A
Gross ProfitN/AN/AN/AN/A$281K-64.2%$143K-74.3%$1K-99.5%N/A
SG&A Expenses$365K-67.7%$410K-34.4%$395K+18.0%$465K$1.1M+370.6%$625K+227.4%$335K-96.1%N/A
Operating Income-$228K+72.0%-$274K+13.0%-$326K+44.6%-$1.1M-$814K-354.1%-$315K+6.1%-$589K+93.5%N/A
EBITDA-$213K+73.2%-$259K-367.7%-$318K+45.8%-$1.5M-$795K-178.5%$97K-76.4%-$586K+93.0%N/A
Interest Expense$13K+0.5%$14K+4.9%$13K-0.9%$14K$13K-45.4%$13K-45.6%$13K-43.3%N/A
Income Tax$0$0$0$0$0$0$0N/A
Net Income-$240K+59.2%-$288K+57.3%-$652K+46.4%-$1.1M-$589K-298.0%-$674K-87.4%-$1.2M+86.6%N/A
EPS (Basic)-$0.04+60.0%-$0.05+16.7%-$0.09+30.8%-$0.18+58.1%-$0.10-350.0%-$0.06+53.8%-$0.13-$0.43
EPS (Diluted)-$0.04+60.0%-$0.05+61.5%-$0.09+30.8%-$0.18+58.1%-$0.10-$0.13-$0.13-$0.43
Diluted Shares (Avg)N/AN/AN/AN/A6M5MN/AN/A

Not reported in any period shown, so not listed: R&D Expenses.

MWAI Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

MWAI quarterly balance sheet
MetricQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-K
Total Assets$322K-83.0%$461K-83.6%$550K-84.0%$806K-79.6%$1.9M-68.2%$2.8M-48.3%$3.4M-40.0%$3.9M-40.2%
Current Assets$165K-78.5%$164K-89.1%$242K-86.3%$419K-83.9%$766K-62.0%$1.5M+4681.1%$1.8M+2470.6%$2.6M+264.8%
Cash & Equivalents$130K-73.0%$138K-41.4%$223K-70.2%$401K+594.1%$482K+26.3%$235K+754.3%$750K+1200.0%$58K-77.6%
Short-Term Investments$0$0$0$0$0$0$0$0
Long-Term Investments$0$0$0$0$0$0$0$0
GoodwillN/AN/AN/AN/A$670K$670K$670K$0
Total Liabilities$8.0M+7.7%$7.9M-4.3%$7.8M-6.0%$7.4M-4.8%$7.4M+0.1%$8.3M+15.7%$8.3M+15.2%$7.8M+10.0%
Current Liabilities$7.8M+157.8%$7.7M+101.9%$7.5M+101.5%$3.1M-17.0%$3.0M-8.8%$3.8M+25.7%$3.7M+22.4%$3.7M+23.8%
Non-Current Liabilities$231K-94.8%$237K-94.7%$243K-94.6%$4.4M+6.0%$4.4M+7.2%$4.5M+8.3%$4.5M+9.9%$4.1M0.0%
Total Equity-$7.7M-38.6%-$7.5M-36.5%-$7.2M-49.5%-$6.6M-71.4%-$5.5M-273.9%-$5.5M-219.6%-$4.8M-233.3%-$3.9M-658.1%
Retained Earnings-$89.9M-202.6%-$89.6M-3.1%-$89.3M-3.5%$88.7M+204.2%$87.5M+205.9%-$87.0M-4.9%-$86.3M-4.8%-$85.1M-16.4%

Not reported in any period shown, so not listed: Inventory, Accounts Receivable, Long-Term Debt.

MWAI Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

MWAI quarterly cash flow statement
MetricQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-K
Operating Cash Flow-$7K+97.3%-$85K+60.8%-$171K+30.3%-$109K-$278K+69.6%-$217K+84.1%-$245K+73.8%N/A
Depreciation & Amortization$15K-23.4%$15K-96.5%$8K+197.5%$5K$19K-97.3%$412K-44.7%$3K-99.6%N/A
Stock-Based CompensationN/AN/A$49KN/AN/AN/A$0-100.0%N/A
Capital Expenditures$0N/AN/A$0$0$0-100.0%$2KN/A
Free Cash Flow-$7K+97.3%N/AN/A-$109K-$278K+69.6%-$217K+84.1%-$247K+73.5%N/A
Investing Cash Flow$0-100.0%-$750+99.7%-$7K-100.8%$28K$526K-61.4%-$299K-121.6%$937K+20.0%N/A
Financing Cash Flow$0$0$0$0$0+100.0%$0+100.0%$0+100.0%N/A

Not reported in any period shown, so not listed: Dividends Paid, Share Buybacks.

MWAI Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

MWAI quarterly financial ratios
MetricQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-K
Gross MarginN/AN/AN/AN/A100.0%+60.4pp100.0%+67.8pp100.0%+79.3ppN/A
Operating Margin-36.8%-50.0%-339.3%-662.4%-289.4%-220.6%-51305.2%N/A
Net Margin-38.8%-52.4%-678.4%-666.0%-209.2%-471.7%-105927.4%N/A
Return on Assets-74.7%-43.6pp-62.4%-38.5pp-118.5%-83.2pp-140.1%-31.1%-36.1pp-23.9%-17.3pp-35.4%+123.2ppN/A
Current Ratio0.02-0.2x0.02-0.4x0.03-0.4x0.14-0.6x0.25-0.4x0.40+0.4x0.47+0.4x0.71+0.5x
Asset Turnover1.92+1.8x1.19+1.1x0.17+0.2x0.210.15-0.2x0.05-0.3x0.00-0.2xN/A
FCF Margin-1.2%+97.7ppN/AN/A-64.2%-98.9%-52.8pp-151.7%-21526.7%N/A

Not reported in any period shown, so not listed: Return on Equity, Debt-to-Equity.

Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Operating Margin, Net Margin, FCF Margin.

Note: Shareholder equity is negative (-$6.6M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.

Note: The current ratio is below 1.0 (0.14), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company Fiscal year Revenue Net income Net margin Market cap Health score
MEDWELLAI INC MWAI FY2025 $595K -$3.6M N/A N/A —
METAVESCO INC. MVCO FY2023 $127K -$573K N/A $2.9M —

Frequently Asked Questions

What is MEDWELLAI INC's annual revenue?

MEDWELLAI INC (MWAI) reported $595K in total revenue for fiscal year 2025. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

Is MEDWELLAI INC profitable?

No, MEDWELLAI INC (MWAI) reported a net income of -$3.6M in fiscal year 2025.

What is MEDWELLAI INC's earnings per share (EPS)?

MEDWELLAI INC (MWAI) reported diluted earnings per share of -$0.49 for fiscal year 2025. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

MEDWELLAI INC (MWAI) had EBITDA of -$2.8M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

MEDWELLAI INC (MWAI) recorded an outflow of $851K in free cash flow during fiscal year 2025. This represents a 79.4% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

MEDWELLAI INC (MWAI) recorded an outflow of $849K in operating cash flow during fiscal year 2025, representing cash used by core business activities.

MEDWELLAI INC (MWAI) had $806K in total assets as of fiscal year 2025, including both current and long-term assets.

MEDWELLAI INC (MWAI) invested $2K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

MEDWELLAI INC (MWAI) had 6M shares outstanding as of fiscal year 2025.

MEDWELLAI INC (MWAI) had a current ratio of 0.14 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.

MEDWELLAI INC (MWAI) had a return on assets of -447.8% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

MEDWELLAI INC (MWAI) has negative shareholder equity of -$6.6M as of fiscal year 2025, so no debt-to-equity ratio is reported: dividing debt by equity that is not positive produces a number that cannot be read as leverage. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.

MEDWELLAI INC (MWAI) has a Piotroski F-Score of 2 out of 7 computable signals; 2 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

MEDWELLAI INC (MWAI) reported a net loss of $3.6M while operations used $849K of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

MEDWELLAI INC (MWAI) reported an operating loss of $2.8M against $52K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

Back to top